↓ Skip to main content

Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmonary disease

Overview of attention for article published in BMC Pulmonary Medicine, July 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
93 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmonary disease
Published in
BMC Pulmonary Medicine, July 2014
DOI 10.1186/1471-2466-14-118
Pubmed ID
Authors

Stephen Rennard, Charles Fogarty, Colin Reisner, Carlos Fernandez, Tracy Fischer, Michael Golden, Earl St Rose, Patrick Darken, Gregory Tardie, Chadwick Orevillo

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
Unknown 92 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 18%
Student > Master 14 15%
Student > Bachelor 10 11%
Other 8 9%
Student > Ph. D. Student 6 6%
Other 18 19%
Unknown 20 22%
Readers by discipline Count As %
Medicine and Dentistry 40 43%
Nursing and Health Professions 6 6%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Agricultural and Biological Sciences 6 6%
Mathematics 2 2%
Other 6 6%
Unknown 27 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 May 2018.
All research outputs
#7,499,357
of 22,919,505 outputs
Outputs from BMC Pulmonary Medicine
#586
of 1,934 outputs
Outputs of similar age
#73,288
of 227,177 outputs
Outputs of similar age from BMC Pulmonary Medicine
#12
of 37 outputs
Altmetric has tracked 22,919,505 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,934 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 227,177 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.